Ambroxol Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 30 mg, 60 mg, or 75 mg
Reference Brands: Mucosolvan(EU)
Category:
Medical Aid
Ambroxol tablets work by stimulating mucus production and enhancing ciliary function, promoting the clearance of thick mucus from airways. They also have anti-inflammatory properties. Benefits include improved airway clearance, reduced cough, and relief from respiratory conditions like bronchitis and COPD, helping to improve breathing and overall respiratory health.
Ambroxol tablet is available in Tablet
and strengths such as 30 mg, 60 mg, or 75 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ambroxol tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ambroxol tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ambroxol tablets are approved in the EU and other regions, with regulatory oversight from agencies like the EMA. In the US, Ambroxol is not officially approved but is available in some markets globally. Regulatory dossiers include comprehensive safety, efficacy, and manufacturing data aligned with GMP standards. In Europe, products like Mucosolvan are well-established, supported by approved dossiers demonstrating quality and performance. For detailed information on regulatory submissions, approved dossiers, and licensing workflows for Ambroxol tablets, visit Pharmatradz. Stay informed on the latest regulatory updates and licensing requirements for Ambroxol across different markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing